skip to main content

Our network of sites

Recommending working group

The COVID-19 Evidence Network to support Decision-making (COVID-END) has come together to help coordinate and reduce duplication in these remarkable efforts. Its initial focus includes supporting working groups to achieve and document quick-wins, and to establish processes to achieve and document longer-term wins, in seven areas including recommending evidence-based approaches in ways that are more coordinated and efficient and that balance quality and timeliness.

Proposed terms of reference


  1. Providing an initial overview of emerging and existing repositories and initiatives for COVID-19 guidance (completed and underway), through mapping and surveying initiatives and organizations (a focus for May 2020)
  2. Identifying and supporting the most useful repository for trustworthy COVID-19 guidance (“global guidance repository”) that can be re-used, shared and adapted globally and is optimally linked to other repositories of evidence sources (e.g., systematic reviews, evidence tables, economic models) from trustworthy partners such as PAHO, WHO, G-I-N, and others)
  3. Identifying and sharing standards, methods, processes and digital platforms for developing, disseminating, adapting and implementing trustworthy, actionable and living guidance (linked to evidence)


  1. Collaborating with key organizations within  the technology assessment guideline fields to share their COVID-19 guidance and evidence tables to initially feed into COVID-END repository and ultimately the global guidance repository (a primary focus for June 2020 onwards)
  2. Contributing to maintaining the guide to COVID-19 evidence sources and encouraging its use to avoid unnecessary duplication, while coordinating with the global guidance repository
  3. Connecting other COVID-END working groups to guidance activities to reduce duplication and facilitate work among groups (with emphasis in digitizing, synthesizing, and packaging groups)


  1. Developing rapid guidance following trustworthy methods for rapid recommendations (e.g., BMJ rapid recommendations) for selected prioritized questions
  2. Identifying funding opportunities to support guideline organizations with limited capacity in their work on COVID-19 guidelines, through expertise and person-power 
  1. Ivan Florez, AGREE Collaboration, University of Antioquia, Colombia (co-chair)
  2. Per-Olav Vandvik, MAGIC Evidence Ecosystem Foundation, Norway (co-chair)
  3. Amir Qaseem, American College of Physicians, United States
  4. Elie Akl, Systematic Review Centre for Health Policy and Systems, AUB, Lebanon
  5. Ignacio Neumann, Epistemonikos, Chile
  6. Jerry Osheroff
  7. Michael McCaul, Centre for Evidence-based Health Care, Stellenbosch University, South Africa
  8. Mireille Goetghebeur, Institut national d'excellence en santé et en services sociaux, Canada
  9. Lucy Henry, Health Technology Assessment International (HTAi), Canada
  10. Ludovic Reveiz, Pan American Health Organization
  11. Susan Norris, World Health Organization
  12. Tamara Kredo, South African Medical Research Council, South Africa
  13. Xuan Elody, Evidence-Based Medicine Center, China
  14. Zack Munn, GIN, Australia
  15. Secretariat: Mike Wilson and Safa Al-Khateeb, McMaster Health Forum | RISE, Canada and Anna Dion and Jeremy Grimshaw, Ottawa Hospital Research Institute | RISE, Canada

Meeting documents

Meeting date Documents
April 28, 2020
  1. Meeting notes

Explore our guide to all COVID-19 evidence sources to get ideas for how recommendations can be developed in ways that are more coordinated and efficient and that balance quality and timeliness.